ARNA

Arena Pharmaceuticals Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ARNA price

Arena Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ARNA

Valuation

P/E

0.00

Sector -3.50

Industry -3.50

P/BV

0.00

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-1,122.65

Sector -214.99

Industry -214.99

EV/EBIT

1,037.17

Sector -47.59

Industry -47.59

P/EBITDA

Sector -21.41

Industry -21.41

P/EBIT

Sector -28.65

Industry -28.65

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -11.97

Industry -11.97

P/Working Capital

Sector -167.95

Industry -167.95

EPS

-10.08

Sector -1.81

Industry -1.81

BVPS

11.01

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

-1.53%

Sector 41.30%

Industry 41.30%

EBITDA Margin

916,242,820.00%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-991,757,180.00%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.00

Sector 0.02

Industry 0.02

Profitability

ROE

-91.56%

Sector -56.04%

Industry -56.04%

ROA

-78.56%

Sector -60.31%

Industry -60.31%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-1,122.65

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

1,037.17

Sector -8.06

Industry -8.06

Net Debt / Equity

-0.76

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.05

Sector -0.85

Industry -0.85

Equity/Assets

0.86

Sector 0.46

Industry 0.46

Liabilities/Assets

0.14

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ARNA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ARNA Arena Pharmaceuticals Inc.	$0.00	-	0.00%	0.00	0.00	-91.56%	100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARNA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Arena Pharmaceuticals

Arena Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

29 years

Founded: 1997

2000

Time since IPO - 26 years

320

Employees

Arena Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $673.24 million.

The company employs approximately 320 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Arena Pharmaceuticals Inc. reported $-3.53 million in revenue, generating net income of $-616.43 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARNA.

Market cap

Net worth

$673.24 million

$673,237,000.00

Assets

$784.71 million

$784,705,000.00

Total Shares Outstanding

61.14 million

61,140,000

Average Daily Trading Volume

$1.67 million

$1,666,914.84

Sector

Health Care

Industry

Biotechnology

ARNA

ARNA revenue and profits

Financial Results ARNA

DRAG THE FRAME TO SEE MORE DATA

ARNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Arena Pharmaceuticals (ARNA) today?

A cotação de Arena Pharmaceuticals (ARNA) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Arena Pharmaceuticals (ARNA) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Arena Pharmaceuticals (ARNA) e dados de ações do Ibovespa e mercados internacionais.

Quando Arena Pharmaceuticals (ARNA) paga dividendos?

Arena Pharmaceuticals (ARNA) não distribuiu dividendos no último ano.

Is Arena Pharmaceuticals (ARNA) a good investment?

Atualmente, Arena Pharmaceuticals (ARNA) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Arena Pharmaceuticals (ARNA) stock?

Investir em ações de Arena Pharmaceuticals (ARNA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Arena Pharmaceuticals (ARNA) yield today?

A rentabilidade de Arena Pharmaceuticals (ARNA) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Arena Pharmaceuticals (ARNA) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARNA

Arena Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARNA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ARNA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Arena Pharmaceuticals

Arena Pharmaceuticals Inc.

United States

29 years

2000

320

PROFIT X PRICE ARNA

Financial Results ARNA

ARNA cash flow

Asset, Revenue and Profit Growth - ARNA

ARNA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions